Grafeel 300 mcg Filgrastim Injection

Regulated Product — Business License Required

B2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.

Product photography not yet supplied — this space will show official packaging imagery once provided by the business.

Product Overview

Grafeel 300 mcg Filgrastim Injection contains filgrastim, a granulocyte colony-stimulating factor (growth factor). Its labelling describes it for the prevention of infections in patients after chemotherapy. It is described as encouraging the bone marrow to produce white blood cells, which help protect the body against infections. It is given only by a professional doctor or healthcare team in the correct dosage, duration, and interval, and the directions can change as treatment progresses.

Active ingredient
Filgrastim
Strength
300 mcg
Dosage form
Solution for injection (pre-filled syringe / vial)
Therapeutic class
Granulocyte colony-stimulating factor (G-CSF)
Regulatory status
Prescription / regulated — confirmed per enquiry and destination market
Availability
Confirmed per enquiry

Product Information

The following description reflects information associated with this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.

Described Uses

  • Described for the prevention of infections after chemotherapy
  • Described as encouraging the bone marrow to produce white blood cells
  • Described as helping protect the body against infections
Note: SDO Pharma has not independently verified the manufacturer’s efficacy claims for this product and makes no additional medical or clinical claims beyond what is described here. We do not claim FDA, UAE, EU, or other specific regulatory approval for this product unless independently verified. This is a prescription / regulated-status product; patient dispensing is the responsibility of the licensed business customer, not SDO Pharma.

Described Dosage & Administration

  • Given only by a professional doctor or healthcare team, in the correct dosage, duration, and interval
  • The directions for use can change as treatment progresses
  • Regular tests for blood cells and density may be suggested and should be cooperated with

Described Side Effects

Commonly described side effects include:

  • Bone pain
  • Weakness and fatigue
  • Headache
  • Rash
  • Nausea and vomiting
  • Increased uric acid level in the blood
  • Hair loss
  • Diarrhoea and constipation
  • Decreased appetite
  • Cough and breathing problems
  • Injection site reactions (pain, swelling, redness)

These are described as commonly temporary. The doctor should be consulted if they persist.

Precautions

  • Not for pregnant or breastfeeding women
  • Everyone should use effective contraception to avoid pregnancy during the medication
  • Regular tests for blood cells and density may be suggested and should be cooperated with

This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.

B2B, Import & Export

B2B, Import & Export Enquiries

SDO Pharma supports business enquiries for pharmaceutical and healthcare products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.

We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.

Product Enquiry

Request Product Information

Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.

Frequently Asked Questions

Per its labelling it contains filgrastim and is used for the prevention of infections in patients after chemotherapy. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.

Its labelling describes it as given only by a professional doctor or healthcare team, in the correct dosage, duration, and interval, which can change as treatment progresses.

Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.

Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.

Explore More

Related Product Categories

SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.

View Products & Services